Fiorotto, R., Amenduni, M., Cadamuro, M., Spirli, C., Strazzabosco, M. (2017). Identification of Src tyrosine kinase as a therapeutic target in cystic fibrosis liver disease using patient specific induced pluripotent stem cells -derived cholangiocytes. In International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver (pp.182-182). ELSEVIER SCIENCE BV [10.1016/S0168-8278(17)30650-5].

Identification of Src tyrosine kinase as a therapeutic target in cystic fibrosis liver disease using patient specific induced pluripotent stem cells -derived cholangiocytes

Cadamuro, M;Strazzabosco, M
2017

abstract + poster
Cistic fibrosisi, CFTR, c-SRC
English
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver - APR 19-23, 2017
2017
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver
2017
66
1
182
182
none
Fiorotto, R., Amenduni, M., Cadamuro, M., Spirli, C., Strazzabosco, M. (2017). Identification of Src tyrosine kinase as a therapeutic target in cystic fibrosis liver disease using patient specific induced pluripotent stem cells -derived cholangiocytes. In International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver (pp.182-182). ELSEVIER SCIENCE BV [10.1016/S0168-8278(17)30650-5].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/466778
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
Social impact